The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease

Expert Opinion on Drug Safety - Tập 3 Số 5 - Trang 425-440 - 2004
Sarah Thompson1, Krista L. Lanctôt2, Nathan Herrmann2
1Sunnybrook and Women's College Health Sciences Centre, Department of Psychiatry, Rm FG-05, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
2Sunnybrook and Women’s College Health Sciences Centre, Department of Psychiatry, Rm FG-05, Sunnybrook and Women’s College Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1176/ajp.155.10.1458a

10.4088/JCP.v62n07d13

10.1017/S1461145703003857

10.1016/S0140-6736(00)03399-7

10.1002/gps.993

10.1136/jnnp.72.6.708

10.1016/S0531-5565(00)00206-0

10.1111/j.1532-5415.1998.tb01033.x

10.1016/0165-1781(94)90013-2

ROGERS SL, 1998, Donepezil Study Group. Neurology, 50, 136

10.1016/S0140-6736(00)02588-5

10.1093/toxsci/47.1.23

10.1002/gps.599

10.1002/(SICI)1099-1166(200003)15:3<242::AID-GPS110>3.0.CO;2-7

10.2165/00002512-200118110-00006

SANCHEZ MORILLO J, 2003, Rev. Esp. Anestesiol. Reanim., 50, 97

HEATH ML, 2003, Anaesthesia, 58, 202

EMRE M, 2002, Int. J. Clin. Pract. Suppl., 127, 64

10.1185/030079903125002450

EDWARDS KR, 2001, J. Am. Geriatr. Soc., 49, S91–S92

10.1185/030079902125000471

10.1159/000066669

10.1186/1471-2318-3-6

10.1002/gps.811

10.1176/appi.ajp.160.11.2003

10.1016/S0896-6273(00)80108-7

10.1002/ana.410220206

10.1001/jama.291.3.317

10.1097/00004850-200303000-00003

10.1016/S0024-3205(00)00411-2

Thông tin
Thông tin xuất bản

Expert Opinion on Drug Safety

Tập 3 Số 5

425-440

Thông tin tác giả